The Valley Desk

NCT07321652 · Interventional trial

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

Overall registry status Recruiting

Phase 3

Conditions Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov